Drug profile · INN
finasteride
APO-FINASTERIDE
finasteride (APO-FINASTERIDE) is a steroid 5-alpha-reductase 2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — finasteride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 2
- Data quality
- 0.89
Quick answer
finasteride (APO-FINASTERIDE) is a steroid 5-alpha-reductase 2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Steroid 5-alpha-reductase 2 inhibitor
Primary target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is finasteride?
finasteride (APO-FINASTERIDE) is a steroid 5-alpha-reductase 2 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for finasteride?
APO-FINASTERIDE is a marketed brand name for finasteride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of finasteride?
finasteride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.